Skip to main navigation
Skip to main content
Skip to Footer
Global
Novartis Site Directory
Our Work
Product Portfolio
Disease Areas
Clinical Trials
Therapeutic Areas
About Us
Our Mission and Vision
Our Values
Our Strategy
Novartis Leadership
Company History
Our Business
Corporate Responsibility
Contact Us
Products
Product Listing
Patient Assistance
News
BD News Archive
Global Featured News
Global Media Releases
Global Stories
Careers
Careers Search
Working at Novartis
Diversity and Inclusion
Awards & Recognition
Search
BD News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Stories
Filter By
2015
June
Media Release
/
Jun 18, 2015
Sandoz announces US launch of Glatopa(TM), the first generic competitor to Copaxone® 20mg
Read More
Media Release
/
Jun 18, 2015
Novartis highlights strong innovation momentum at its second Meet Novartis Management investor day
Read More
Media Release
/
Jun 16, 2015
Alcon receives European approval for new trifocal presbyopia-correcting intraocular lens for patients undergoing cataract surgery
Read More
Media Release
/
Jun 13, 2015
Novartis presents new data from large European study reinforcing the benefit of first-line Tasigna® in newly-diagnosed patients with CML
Read More
Media Release
/
Jun 13, 2015
Novartis announces data show majority of patients with polycythemia vera treated with Jakavi® achieved long-term disease control
Read More
Media Release
/
Jun 12, 2015
Novartis data at EHA show increased PFS benefit of Farydak® in new subgroup of patients with previously treated multiple myeloma
Read More
Media Release
/
Jun 12, 2015
Novartis drug Arzerra® improved median progression-free survival by 54% in patients with relapsed chronic lymphocytic leukemia
Read More
Media Release
/
Jun 12, 2015
Novartis reports new analysis showing Xolair® improving quality of life by 78% for chronic spontaneous urticaria patients
Read More
Media Release
/
Jun 11, 2015
Novartis gains FDA approval for Promacta® providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder
Read More
Media Release
/
Jun 11, 2015
Novartis presents new data at WCD demonstrating significant efficacy of Cosentyx® in patients with psoriasis of the nails, palms and soles
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
4
of 5
Page
5
of 5
Current page
6
of 5
Page
7
of 5
Page
8
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Google +
Email
Jump to Comments
Print
Save
You are here
Home
›
News